JNJ-68179280 for Healthy Subjects

"This clinical trial requires that 118 participants, ranging in age from 18 to 60 and with no pre-existing conditions, fulfill the following criteria: They must not have smoked or used nicotine products for at least six months prior to screening; female patients need a negative pregnancy test before check-in on either Day -2 or Day -1. At both screening and check-in, their physical examination needs to be healthy as well as all of the results from their serum chemistry panel (excluding liver enzymes), hematology tests, blood coagulation tests and urinalysis. Furthermore, they are required to have specific laboratory values during both stages including"

"This medical experiment is accepting participants who are of legal age and younger than 60 years old."

"Affirmative. According to information hosted on clinicaltrials.gov, this particular medical trial is presently seeking participants and was originally posted on May 5th 2021. 118 patients are needed from 1 site for the study's completion."

"This 35 day trial seeks to assess the number of participants displaying clinically significant abnormal vital signs. Secondary evaluation focuses on measuring clinically noteworthy ECG distortions while fasting, plasma concentration levels after consuming JNJ-68179280, and physical examinations (including general appearance, respiratory system assessment and cardiovascular checkup) post ingestion."

"As it is merely a Phase 1 trial, and therefore still has limited evidence of efficacy or safety, JNJ-68179280 was rated a score of 1."

"Affirmative. According to clinicaltrials.gov, this study remains open and was originally published on May 5th 2021and last modified November 22nd 2022. The research is recruiting 118 patients at a single facility."